Brought to you by 
VitaGen raises $14mm in Series C round
13 Jul 2001
Executive Summary
VitaGen (devices for liver disease patients) completed a Series C private placement raising $14mm from return investors JP Morgan Partners, BD Ventures, Merrill Lynch Ventures, Perseus Capital, Tullis-Dickerson, Essex Woodlands, Pacific Horizon Ventures, Radius Ventures, Triad Ventures, Baylor's BCM Technologies, Alta Partners, and Paragon Ventures.
Deal Industry
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
VitaGen raises $14mm in Series C round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice